81
105. Roose, S. P., Laghrissi-Thode, F., Kennedy, J. S., Nelson, J. C., Bigger, J. T.,
Pollock, B. G., Gaffney, A., Narayan, M., Finkel, M., McCafferty, J., Gergel, I.
Comparison of paroxetine and nortriptyline in depressed patients with ischemic
heart disease.
J. Am. Med. Assoc. 279, 287-291. (1998)
106. Ross, E. D., Rush, A. J.
Diagnosis and neuroanatomical correlates of depression in brain-damaged
patients: Implications for a neurology of depression.
Arch. Gen. Psychiatry. 38,1344-1354. (1981)
107. Rundles, R. W.
Diabetic neuropathy. General review with report of 1264 cases.
Medicine (Baltimore). 24, 1111-1160. (1945)
108. Sakmann, B., Noma, A., Trautwein, W.
Acetylcholine activation of single muscarinic K+ channels in isolated pacemaker
cells of the mammallan heart.
Nature 303, 250-253. (1983)
109. Sampson, M. J., Wilson, S., Karuagiannis, P., Edmonds, M., Watkins, P. J.
Progression of diabetic autonomic neuropathy over a decade in insulin-
dependent diabetics.
Q. J. Med. 75, 635-646. (1990)
110. Saxena, P. R., Villalon, C. M.
Cardiovascular effects of serotonin agonists and antagonists.
J. Cardiovasc. Pharmacol. 15 (suppl.. 7), S17-S34. (1990)
111. Schildkraut, J. J.
The catecholamine hypothesis of affective disorders: A review of supporting
evidence.
Am. J. Psychiatry. 122,509-522. (1965)
112. Schmidt, R. F., Thews, G.
Physiologie des Menschen.
Springer Verlag, 26. Aufl., 1995
113. Schneider, L. S., Sloane, R. B., Staples, F. R., Bender, M.
Pretreatment orthostatic hypotension as a predictor of response to nortriptyline
in geriatric depression.
J. Clin. Psychopharmacol. Jun;6(3):172-6. (1986)
114. Schweizer, E., Feigner, J., Mandos, L. A., Rickels, K.
Comparison of venlafaxine and imipramine in the acute treatment of major
depression in outpatients.
J. Clin. Psychiatry 55, 1-5. (1994)
115. Sharma, R., Markar, H. R.
Mortality in affective disorder.
J. Affect. Disord. 31(2),91-96. (1994)
|
